Orbis Research has published a new report on “Global Generic Drugs Market “. The report provides information on Industry Top Manufacturers, Countries, Material and Applications.
“Global Generic Drugs Market Research and Analysis 2018-2025”:
This report studies the Global Generic Drugs Market size of key regions like North America, Europe, Asia Pacific, Central & South America and Mithe ddle East & Africa, focuses on the consumption of Generic Drugs in these regions.
This research report categorizes the global Generic Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2349171?utm_source=km
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.
In 2017, the global Generic Drugs market size was 210800 million US$ and is forecast to 451800 million US in 2025, growing at a CAGR of 10.0% from 2018. The objectives of this study are to define, segment, and project the size of the Generic Drugs market based on company, product type, application and key regions.
The various contributors involved in the value chain of Generic Drugs include manufacturers, suppliers, distributors, intermediaries, and customers.
Browse the complete report @ http://www.orbisresearch.com/reports/index/global-generic-drugs-market-insights-forecast-to-2025?utm_source=km
The key manufacturers in the Generic Drugs Market include:
- Teva
- Novartis – Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy’s
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
Market Size Split by Type:
- Simple Generic Drugs
- Super Generic Drugs
- Biosimilars
Market Size Split by Application:
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Market size split by Region:
North America: United States, Canada, Mexico
Asia-Pacific: China, India, Japan, South Korea, Australia, Indonesia, Singapore, Malaysia, Philippines, Thailand, Vietnam
Europe: Germany, France, UK, Italy, Spain, Russia
Central & South America: Brazil, Rest of Central & South America
Middle East & Africa: GCC Countries, Turkey, Egypt, South Africa
Make an enquiry of this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2349171?utm_source=km
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Your information will never be shared with any third party.